User profiles for "author:Antonella Ravaggi"

Antonella Ravaggi

Biologo, Universitą degli Studi di Brescia
Verified email at unibs.it
Cited by 6411

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

S Zhao, M Choi, JD Overton… - Proceedings of the …, 2013 - National Acad Sciences
Uterine serous carcinoma (USC) is a biologically aggressive subtype of endometrial cancer.
We analyzed the mutational landscape of USC by whole-exome sequencing of 57 cancers …

[HTML][HTML] Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

E Bignotti, M Ragnoli, L Zanotti, S Calza… - British journal of …, 2011 - nature.com
Background: To date, no good marker for screening or disease monitoring of endometrial
cancer (EC) is available. The aims of this study were to investigate HE4 gene, protein …

Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes

AD Santin, PL Hermonat, A Ravaggi, S Bellone… - Journal of …, 2000 - Am Soc Microbiol
Interleukin-10 (IL-10) is widely known as an immunosuppressive cytokine by virtue of its
ability to inhibit macrophage-dependent antigen presentation, T-cell proliferation, and Th1 …

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition

S Zhao, S Bellone, S Lopez, D Thakral… - Proceedings of the …, 2016 - National Acad Sciences
Carcinosarcomas (CSs) of the uterus and ovary are highly aggressive neoplasms containing
both carcinomatous and sarcomatous elements. We analyzed the mutational landscape of …

Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial

AD Santin, S Bellone, M Palmieri, A Zanolini… - Journal of …, 2008 - Am Soc Microbiol
The safety and immunogenicity of the human papillomavirus type 16 (HPV16) or HPV18
(HPV16/18) E7 antigen-pulsed mature dendritic cell (DC) vaccination were evaluated for …

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management

E Bandiera, C Romani, C Specchia, L Zanotti… - … , biomarkers & prevention, 2011 - AACR
Background: The aim of this work was to analyze the diagnostic and prognostic value of
serum human epididymis protein 4 (HE4) and Risk for Ovarian Malignancy Algorithm …

HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm

G Ruggeri, E Bandiera, L Zanotti, S Belloli… - Clinica Chimica …, 2011 - Elsevier
Background Two commercial immunoassays for HE4 have been compared and the
diagnostic accuracy of HE4, CA 125 and the combinatory ROMA algorithm for epithelial …

HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study

C Romagnolo, AE Leon, ASC Fabricio, M Taborelli… - Gynecologic …, 2016 - Elsevier
Objective This multicenter study aims to evaluate HE4, CA125 and risk of ovarian
malignancy algorithm (ROMA) performance in the differential diagnosis of epithelial ovarian …

Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients

E Bignotti, P Todeschini, S Calza, M Falchetti… - European journal of …, 2010 - Elsevier
BACKGROUND: Prognostic factors currently available are insufficient to predict the clinical
course of epithelial ovarian cancer (EOC). In a previous microarray study we identified the …

[HTML][HTML] Prognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancer

E Bandiera, R Franceschini, C Specchia… - International Scholarly …, 2012 - hindawi.com
Introduction. We performed a review of the literature to elucidate the potential prognostic
significance of serum vascular endothelial growth factor (sVEGF) levels in ovarian cancer …